Drugs / Kanglaite Injection
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00031031 | Jun 2001 → Nov 2002 | neoplasm | KangLaiTe USA | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Kanglaite Injection | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00031031 ↗ |
| Known as | KLT | “The Kanglaite Injection (KLT)is a novel broad spectrum anti-cancer injection produced from traditional Chinese medicinal herbs (the Coix Seed).” NCT00031031 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “produced from traditional Chinese medicinal herbs (the Coix Seed)” NCT00031031 ↗ |